Old Web
English
Sign In
Acemap
>
Paper
>
Metastasiertes NSCLC: Pembrolizumab First-Line verbessert die Langzeitprognose
Metastasiertes NSCLC: Pembrolizumab First-Line verbessert die Langzeitprognose
2021
Dagmar Kraus
Keywords:
Oncology
Pembrolizumab
Internal medicine
first line
Medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]